PRECISely how can PRECIS-2 help design trials to achieve practical answers to “real world” questions? Kirsty Loudon Impact Fellow NMAHP Research Unit  

Slides:



Advertisements
Similar presentations
Kirsty McCormack.
Advertisements

SMI Stakeholder Event, 7 th March, 2013 SMI Education and Training start and finish group: SMI workforce development: Service innovation and transformation.
PrECIs (Pragmatic-Explanatory Continuum Indicators) “Spokes” Dave Sackett, on behalf of at least 23 collaborators.
Developing and Maintaining Quality and Safety Competencies Linda Cronenwett, PhD, RN, FAAN Professor and Former Dean Co-Director, RWJF Executive Nurse.
Dementia in Residential Care: Education Intervention Trial Project Team: Chris Beer (Principle Investigator) Kelly Banz (Study Coordinator) Nada Eltaiba.
Research Techniques Made Simple: Pragmatic or Explanatory Trial? The BLISTER Study The Bullous Pemphigoid Steroids and Tetracyclines Study Hywel Williams.
Pragmatic or explanatory trial? Hywel Williams University of Nottingham with help from Daniel Bratton and Andrew Nunn MRC Clinical Trials Unit HTA reference.
Evaluation is a professional and ethical responsibility and is a core part of PHN professional practice Commitment to evaluation helps build the PHN intelligence.
Challenge Questions How well do we meet the need of our stakeholders?
1 Simon Bradstreet: SRN Allison Alexander: NHS Education for Scotland/SRN Scottish Recovery Indicator.
My Own Health Report: Case Study for Pragmatic Research Marcia Ory Texas A&M Health Science Center Presentation at: CPRRN Annual Grantee Meeting October.
Implementation of the Essential Standards The Australian Quality Framework (AQTF) is the national set of standards which assures nationally consistent,
Overview of Evaluation Designs. Learning objectives By the end of this presentation, you will be able to: Explain evaluation design Describe the differences.
Planning an improved prevention response in middle childhood Ms. Melva Ramirez UNODC Regional Office for Central America and the Caribbean.
Randomised controlled trials in primary care: case study Doctor Sue Wilson University of Birmingham United Kingdom.
Care Enough to Count: Measuring Teacher Performance Ronnie Detrich Wing Institute.
Workshop 1 - Report IMPS IMproving Care in a Pregnancy after Stillbirth Central Manchester University Hospitals NHSFT University Hospital of South Manchester.
Mental Health System Reform – What does is mean for me?
Information Sharing for Integrated Care A 5 Step Blueprint.
Why are we Here? Russell E. Glasgow, Ph.D. University of Colorado School of Medicine With thanks to the NIH Health Care Systems Research Collaboratory.
WELCOME! Pragmatic Trials Training Workshop 2014.
Evaluation Planning Checklist (1 of 2) Planning Checklist Planning is a crucial part of the evaluation process. The following checklist (based on the original.
Supported by: Student Hubs is a registered charity in England and Wales, number Impact Measurement Proving and Improving your Social Impact.
PRAGMATIC Study Designs: Elderly Cancer Trials
The PRECIS-2 tool: Matching Intent with Methods David Hahn, MD, MS, WREN Director Department of Family Medicine & Community Health University.
Logic Models How to Integrate Data Collection into your Everyday Work.
Knowledge for Healthcare: Driver Diagrams October 2016
Translating Research Into Practice: Pragmatic Research Approaches
Pragmatic Trial Case Example
Incorporating Evaluation into a Clinical Project
Title Investigators and sites. Clinical Trial Proposal Presentation Template for open forum at the 2017 ASM.
Impact and the Physical Sciences
MODULE 12 – STRATEGIC MANAGEMENT
Self Assessment for Pastoral Care
Support for English, maths and ESOL Module 5 Integrating English, maths and ICT into apprenticeship programmes.
Study Population and Setting
Information Sharing for Integrated care A 5 Step Blueprint
Clinical Studies Continuum
Use of PRECIS-2 Ratings to Advance Understanding of Pragmatic Trial Design Domains: NIH Funded Trials (USA) Paula Darby Lipman, Ph.D. Westat Rockville,
Evaluation of 15 projects – ‘Supporting School Leavers’
Study Population and Setting
Conducting Efficacy Trials
Stakeholder Engagement Plan: Background to Roles and Responsibilities
What can implementation research offer?
MAKING PRAGMATIC TRIALS WORK operational challenges & decision support tool ‘PragMagic’ So John Norrie discussed why there is a need for pragmatic trials,
Staff in a Talk English Here training session
Professor Stephen Pilling PhD
Professional Certificate in Strategic Change Management
Football Fans in Training
Successful Measuring: Outputs, Outcomes & Logic Models
Evaluation Goal: Ensure learnings from the program are identified and recorded, in particular: What roles can CHCs best play in addressing SDOH? What types.
Clinical Research: Part 3 RCTs
What is Healthy Living Pharmacy?
Engaging Patients and Families as Partners
Clinical Research: Part 3 RCTs
ДАРБИ КАРИЕРНа ориентация
The Pragmatic Trial at 50 ICTMC 2017 May 9th
Applying PRECIS-2 to primary care trials
Gem Complete Health Services
Key Legislative Outcomes 2017
PRECIS-2 : A Funder’s View
Objectives The role courage plays in making a difference for yourself and others Understanding the impact fear has on personal and organizational performance.
Decision-making & Internal Factors
Engaging about major service change in GP Practice
Regulatory Perspective of the Use of EHRs in RCTs
Project Management Method and PMI ® PMBOK ® Roles
Nancy Padian UC Berkeley
Why do we request a PIR? The information provided in the PIR helps inspectors to understand how the service meets the five key questions and the plans.
What Do the Guidelines Say About The Role of the HF Nurse?
Western Bay of Plenty Public Transport Implementation Plan 2019/ /22
Presentation transcript:

PRECISely how can PRECIS-2 help design trials to achieve practical answers to “real world” questions? Kirsty Loudon Impact Fellow NMAHP Research Unit   E-mail: Kirsty.loudon@stir.ac.uk Twitter: @KirstyLoudon @PRECIS_2 Skype: Kirsty3

Why? Pragmatic trials – Trials that test if an intervention will work in usual conditions Explanatory trials – Trials that test if an intervention will work in highly controlled, ideal circumstances Continuum not Dichotomy Explanatory and pragmatic attitudes in therapeutical trials (1967). Schwartz D, Lellouch J. Republished in J Clin Epidemiol. 2009;62(5):499-505

PRECIS-2 wheel

How to use PRECIS-2? Why are you doing your trial? Are you taking an explanatory approach to answer the question “Can this intervention work under ideal conditions? Are you taking a pragmatic approach and answer the question ‘Does this intervention work under usual conditions? Consider the trial design choices for each of the PRECIS-2 domains Score 1-5 for these choices and/or mark on the PRECIS wheel Review your choices, reiterate if necessary.

PRECIS-2 key feature Improve applicability of trial results HELP trialists think about consequences of design decisions So trialists consider “how different is the trial…. to usual care”

PRECIS-2 domains 1. Eligibility—To what extent are the participants in the trial similar to those who would receive this intervention if it was part of usual care? 2. Recruitment—How much extra effort is made to recruit participants over and above what would be used in the usual care setting to engage with patients? 3. Setting—How different are the settings of the trial from the usual care setting?

Organisation domain in PRECIS-2 How different are the resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care? For example, score 5 for very pragmatic choice with identical organisation to usual care; score 1 for a very explanatory approaches if the trial increases staff levels, gives additional training, requires more than usual experience or certification and increase resources. Eg ARDSNET

PRECIS-2 domains 5. Flexibility (delivery)—How different is the flexibility in how the intervention is delivered and the flexibility anticipated in usual care? 6. Flexibility (adherence)—How different is the flexibility in how participants are monitored and encouraged to adhere to the intervention from the flexibility anticipated in usual care? 7. Follow-up—How different is the intensity of measurement and follow-up of participants in the trial from the typical follow-up in usual care? 8. Primary outcome—To what extent is the trial’s primary outcome directly relevant to participants? 9. Primary analysis—To what extent are all data included in the analysis of the primary outcome?